{"id":"midazolam-active-comparator","safety":{"commonSideEffects":[{"rate":null,"effect":"Sedation"},{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Amnesia"}]},"_chembl":{"chemblId":"CHEMBL655","moleculeType":"Small molecule","molecularWeight":"325.77"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Midazolam binds to GABA-A receptors in the central nervous system, potentiating the effect of the inhibitory neurotransmitter GABA. This results in sedation, anxiolysis, muscle relaxation, and anticonvulsant effects. The drug is commonly used for procedural sedation, anxiety management, and seizure control in acute settings.","oneSentence":"Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at the GABA-A receptor, depressing central nervous system activity.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:55:10.376Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Procedural sedation and anxiolysis"},{"name":"Acute seizure management"},{"name":"Preoperative anxiety"},{"name":"Sedation in intensive care settings"}]},"trialDetails":[{"nctId":"NCT06608277","phase":"PHASE2","title":"Ketamine, SGB and Combination Treatment for TBI","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2025-07-02","conditions":"Posttraumatic Headache, Posttraumatic Stress Disorder","enrollment":175},{"nctId":"NCT07020988","phase":"PHASE1","title":"A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy Participants","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2025-06-12","conditions":"Healthy Participants","enrollment":55},{"nctId":"NCT05751863","phase":"NA","title":"Analgesia-First Sedation in Trauma Patients","status":"RECRUITING","sponsor":"MemorialCare Health System","startDate":"2023-04-01","conditions":"Mechanical Ventilation, Respiratory Failure","enrollment":170},{"nctId":"NCT05577585","phase":"NA","title":"Ketamine in OCD: Efficacy and Effects on Stress and Cognition","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2022-10-01","conditions":"Obsessive-Compulsive Disorder, Psychiatric Disorder","enrollment":60},{"nctId":"NCT07021521","phase":"NA","title":"Midazolam Efficacy/Safety in Pre-Eclamptic C-Section Sedation","status":"COMPLETED","sponsor":"Zhuji People's Hospital of Zhejiang Province","startDate":"2021-04-05","conditions":"Midazolam, Pre-eclampsia, Cesarean Section","enrollment":124},{"nctId":"NCT06930599","phase":"NA","title":"Circumferential Pulmonary Vein Isolation Plus Transition Zone Modification in Atrial Fibrillation Patients Without Low-Voltage Areas","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2025-04-09","conditions":"Atrial Fibrillation (AF)","enrollment":162},{"nctId":"NCT03399838","phase":"PHASE4","title":"Comparing in Dexmedetomidine With po/pr Midazolam for Procedural Sedation in the Pediatric Emergency Department","status":"WITHDRAWN","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2023-08","conditions":"Procedural Anxiety, Emergencies","enrollment":""},{"nctId":"NCT04019834","phase":"EARLY_PHASE1","title":"Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2020-07-06","conditions":"Breast Cancer, Mastectomy, Anesthesia, Local","enrollment":21},{"nctId":"NCT04745260","phase":"NA","title":"Intranasal Fentanyl in Combination With Midazolam Versus Midazolam Alone for Pediatric Facial Laceration Repair","status":"UNKNOWN","sponsor":"University of Texas at Austin","startDate":"2021-03-01","conditions":"Facial Laceration, Anxiety","enrollment":100},{"nctId":"NCT03436121","phase":"PHASE2, PHASE3","title":"Single-dose Ketamine for the Reduction of Pain and Depression in the Emergency Department","status":"WITHDRAWN","sponsor":"Maria Pacella","startDate":"2019-12","conditions":"Acute Pain, Depression","enrollment":""},{"nctId":"NCT02985697","phase":"PHASE4","title":"Safety and Efficacy of Intranasal Dexmedetomidine","status":"UNKNOWN","sponsor":"Bon Secours Pediatric Dental Associates","startDate":"2017-01","conditions":"Safety and Efficacy of Intranasal Dexmedetomidine","enrollment":100},{"nctId":"NCT02629146","phase":"PHASE4","title":"Analgesic Effects of Midazolam in Human Volunteers","status":"COMPLETED","sponsor":"Wilhelminenspital Vienna","startDate":"2015-12","conditions":"Analgesic Drugs, Antinociceptive Agents","enrollment":24},{"nctId":"NCT01925898","phase":"PHASE4","title":"A Randomized, Clinical Trial of Oral Midazolam Versus Oral Ketamine for Sedation During Laceration Repair.","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2013-08","conditions":"Lacerations","enrollment":60},{"nctId":"NCT00750191","phase":"PHASE1","title":"Placebo-controlled Trial of Transdiscal Radiofrequency Annuloplasty","status":"COMPLETED","sponsor":"Baylis Medical Company","startDate":"2007-09","conditions":"Lower Back Pain","enrollment":64},{"nctId":"NCT01275547","phase":"PHASE2, PHASE3","title":"The Analgesic Effect of Combined Treatment With Intranasal S-ketamine and Intranasal Midazolam","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2011-01","conditions":"Analgesia, Patient-controlled, Spinal Stenosis","enrollment":22}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dormicum"],"phase":"marketed","status":"active","brandName":"Midazolam - active comparator","genericName":"Midazolam - active comparator","companyName":"Assaf-Harofeh Medical Center","companyId":"assaf-harofeh-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at the GABA-A receptor, depressing central nervous system activity. Used for Procedural sedation and anxiolysis, Acute seizure management, Preoperative anxiety.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}